Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Cipolla (Hayward, CA, United States of America), A. Davis (Research Triangle Park, NC, United States of America), J. Froehlich (Hayward, CA, United States of America), I. Gonda (Hayward, CA, United States of America), B. Thompson (Owings Mills, MD, United States of America). Reduction of pulmonary exacerbations in two phase 3 Trials: in-depth analyses. 4954

Member's Comments

No comment yet.

Related content which might interest you: Validation of the recording of acute exacerbations of COPD in the clinical practice research datalink: Phase 1 results Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Lung function with aclidinium/formoterol fixed-dose combination: Pooled analysis of two phase III studies in COPD Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Regional analysis of COPD exacerbation rates in the DYNAGITO trial Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Efficacy of aclidinium bromide in patients with stable COPD: Pooled analysis of phase III data by GOLD 2013 criteria Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Session 1: Characterisation and features of severe exacerbations of COPD - General discussion Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC Year: 2021 Effect of aclidinium bromide on exacerbations in patients with moderate-to-severe COPD: Pooled analysis of phase III studies Source: International Congress 2014 – Bronchodilators for asthma and COPD Year: 2014 Evaluating cardiac safety of tiotropium in patients with COPD: Combined analysis of Holter-ECG data from four trials Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Analysis of comorbidities and treatment patterns by GOLD 2013 criteria: Pooled data from Phase III aclidinium bromide studies Source: International Congress 2014 – Asthma and COPD management Year: 2014 Omalizumab add-on therapy reduces exacerbations among responders: A pooled NNT analysis from 5 phase 3 studies Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Design of pulmonary rehabilitation programmes during acute exacerbations of COPD: a systematic review and network meta-analysis Source: Eur Respir Rev, 29 (158) 200039; 10.1183/16000617.0039-2020 Year: 2020 Results from UK HOT-HMV Trial: Clinical importance of recovery of hypercapnia following acute life-threatening exacerbation of COPD Source: International Congress 2018 – New insights in the management of chronic respiratory failure Year: 2018 Late Breaking Abstract - Small airways dysfunction predicts asthma control and exacerbations: Longitudinal Data from  ATLANTIS Study Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Efficacy of revefenacin based on GOLD 2017 categories: reanalysis of phase 3 data in patients with COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials Source: Eur Respir J 2016; 47: 243-253 Year: 2016 Phase angle versus conventional bioelectric impedance analysis in patients hospitalised with an acute exacerbation of COPD Source: International Congress 2014 – Latest insights in physical activity, exercise testing and muscles Year: 2014 Late Breaking Abstract - Extrafine triple therapy reduces exacerbations in GOLD B COPD patients: post-hoc analysis of TRILOGY and TRINITY Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Characteristics of COPD patients with repeated exacerbations: preliminary results from the PRE-SPIRO survey Source: Annual Congress 2008 - COPD epidemiology Year: 2008 Late Breaking Abstract - Preliminary analysis of the data of patients with severe bronchial asthma included in the Russian National Register of Severe Asthma (RSAR) Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019